SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-006018
Filing Date
2021-05-19
Accepted
2021-05-19 10:03:57
Documents
20
Period of Report
2021-05-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm 8-K 25059
2 PRESENTATION gtbp_ex991.htm EX-99.1 16619
3 IMAGE gtbp_ex991000.jpg GRAPHIC 22126
4 IMAGE gtbp_ex991001.jpg GRAPHIC 82280
5 IMAGE gtbp_ex991002.jpg GRAPHIC 52541
6 IMAGE gtbp_ex991003.jpg GRAPHIC 36872
7 IMAGE gtbp_ex991004.jpg GRAPHIC 47329
8 IMAGE gtbp_ex991005.jpg GRAPHIC 58153
9 IMAGE gtbp_ex991006.jpg GRAPHIC 59946
10 IMAGE gtbp_ex991007.jpg GRAPHIC 40642
11 IMAGE gtbp_ex991008.jpg GRAPHIC 45236
12 IMAGE gtbp_ex991009.jpg GRAPHIC 33112
13 IMAGE gtbp_ex991010.jpg GRAPHIC 39009
14 IMAGE gtbp_ex991011.jpg GRAPHIC 46583
15 IMAGE gtbp_ex991012.jpg GRAPHIC 49848
16 IMAGE gtbp_ex991013.jpg GRAPHIC 43406
17 IMAGE gtbp_ex991014.jpg GRAPHIC 47155
18 IMAGE gtbp_ex991015.jpg GRAPHIC 38685
19 IMAGE gtbp_ex991016.jpg GRAPHIC 52254
20 IMAGE gtbp_ex991017.jpg GRAPHIC 22167
  Complete submission text file 0001654954-21-006018.txt   1170741
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 21938746
SIC: 2834 Pharmaceutical Preparations